I
Isomorphic Labs
Core neolabAI drug discovery built on AlphaFold-derived models
Raised, confirmed$2.7B2 confirmed rounds
Valuation, confirmed—none disclosed
Valuation, reported$50B8 Oct 2026, not confirmed
Founded2021London, GB
Key facts
| Field | Value | Source · checked |
|---|---|---|
| Classification | Core neolabAlphabet spin-out founded in 2021 by Demis Hassabis building AI models for drug discovery; $2.1 billion Series B led by Thrive Capital (May 2026) after a $600 million first external round (Mar 2025). | |
| Founded | 2021 | techcrunch.com the AI drug-discovery platform that was spun out of Google's DeepMind in 2021checked 9 Nov 2026 |
| Headquarters | London, GBAlso offices in Lausanne, Switzerland and Cambridge, MA. | isomorphiclabs.comchecked 9 Nov 2026 |
| Founders | Demis Hassabis | |
| Website | isomorphiclabs.com | isomorphiclabs.com Isomorphic Labs is building a future where frontier AI can help to unlock deeper scientific insights, faster breakthroughs, and life-changing medicines.checked 9 Nov 2026 |
| Careers | isomorphiclabs.com43 open roles on 9 Nov 2026 | isomorphiclabs.comchecked 9 Nov 2026 |
| Profiles and work | X @IsomorphicLabsLinkedInWikidata | How links are checkedchecked 10 Nov 2026 |
Funding rounds
Isomorphic Labs has raised $2.7B in rounds confirmed by the company, a regulator or two independent outlets. Rounds marked Reported or Abandoned are not included in that total. Status rules: methodology.
| Date | Round | Amount | Valuation | Investors | Status | Source · checked |
|---|---|---|---|---|---|---|
| 8 Oct 2026 | Funding round | $5B | $50B | not disclosed | Reported | SiliconANGLE The paper’s sources did, however, divulge that Isomorphic is eyeing a valuation of between $40 billion and $50 billion.+1 more sourcechecked 9 Nov 2026 |
| 12 May 2026 | Series B | $2.1B | — | Lead: Thrive Capital; Alphabet, GV, MGX, Temasek, CapitalG, UK Sovereign AI Fund | Confirmed | Isomorphic Labs Isomorphic Labs announces it has raised $2.1 Billion in Series B funding.+1 more sourcechecked 9 Nov 2026 |
| 31 Mar 2025 | Series A | $600M | — | Lead: Thrive Capital; GV, Alphabet | Confirmed | Isomorphic Labs Isomorphic Labs announces it has raised $600 Million in its first external funding round.+2 more sourceschecked 9 Nov 2026 |
Notes on these rounds
- 8 Oct 2026 Funding round: Reported talks only. Bloomberg reported on 8 October 2026 a valuation of $40 billion to $50 billion, and on 4 November 2026 talks to raise about $5 billion at a valuation of about $50 billion; the financing had not closed.
- 12 May 2026 Series B: The company did not state a valuation in its announcement.
- 31 Mar 2025 Series A: First external funding round.
People
| Name | Role | Before | Now | Source · checked |
|---|---|---|---|---|
| Demis HassabisXLinkedInScholarSite | Founder & CEO | Google DeepMind (CEO) | Current | |
| Max JaderbergXLinkedInScholarSite | President | DeepMind (Research scientist) | Current | |
| Miles CongreveXLinkedInScholar | Chief Scientific Officer | Sosei Heptares (Chief Scientific Officer) | Current | |
| Ben Wolf | Chief Medical Officer | — | Current |
Professional facts from public sources only. How people records are handled.
What it has shipped
| Name | Kind | Date | Open weights | Source · checked |
|---|---|---|---|---|
| IsoDDE | product | Feb 2026 | No | isomorphiclabs.com From our experience of applying IsoDDE to many problems to date, we have seen we are able to find functional molecules for problems with which others have greatly struggled.checked 9 Nov 2026 |
Latest posts on X
The most recent posts from @IsomorphicLabs, the X account of Isomorphic Labs, quoted as posted. Replies and reposts are left out. How posts are selected.
Want to learn how our AI team is working towards a new future for how medicines are designed and made? Don’t miss IsoLabs at #NeurIPS2026. We’ll be in Sydney, Paris, and Atlanta, unpacking our core technical philosophy and sharing how we leverage SOTA agentic models, our conviction in building simulation and world models, and our plan to unlock the bottlenecks holding AI for biology back today. If you’re working on AI and want to see its impact in life sciences, let’s talk. bit.ly/4Ae6tvR
View the post on X · With 1 image
Nobel laureate Sir Paul Nurse literally mapped out the control of cell division. He recently spent time with us, doing what he does best: asking the hard questions that push our science further and challenge our team to keep thinking bigger.
View the post on X · With 1 image
Operating ML at scale is a constant battle of trade-offs: 1. Scaling thousands of models without the rigidity and complexity of ML frameworks 2. Preventing your scheduler from stalling under massive, bursty workloads We're covering both at #KubeCon NA.
View the post on X · With 1 image
checked 10 Nov 2026
Commonly cited, checked
Figures and statements about Isomorphic Labs that circulate in lists and summaries, and what the sources support.
| Claim | Finding | Source |
|---|---|---|
| About $17.5B after the $2.1B Series B | The company's Series B announcement does not state a valuation. | isomorphiclabs.com Isomorphic Labs announces it has raised $2.1 Billion in Series B funding. |
| Talks to raise at a $40-50B valuation (Oct 2026) | Bloomberg reported early talks on 8 Oct 2026 with a target valuation of $40-50 billion; no deal announced and no round size reported. | siliconangle.com Isomorphic is eyeing a valuation of between $40 billion and $50 billion. |
| Alphabet | Series B was led by Thrive Capital with Alphabet, GV, MGX, Temasek, CapitalG and the UK Sovereign AI Fund; Series A was also led by Thrive Capital. | isomorphiclabs.com The financing round is led by Thrive Capital |
Work at Isomorphic Labs, or see something wrong? Update this profile with a public source. How corrections work.